Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07909 | 32314395 | Lipids | High Glucose and Liver Fatty Acid Binding Protein Gene Ablation Differentially Impact Whole Body and Liver Phenotype in High-Fat Pair-Fed Mice. | 2020 | Details |
| A07910 | 32314167 | Indian J Gastroenterol | Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. | 2020 | Details |
| A07914 | 32312689 | Best Pract Res Clin Obstet Gynaecol | Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. | 2020 | Details |
| A07919 | 32309672 | Contemp Clin Trials Commun | Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. | 2020 | Details |
| A07922 | 32308060 | Free Radic Res | Emerging connections between oxidative stress, defective proteolysis, and metabolic diseases. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07929 | 32306653 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children]. | 2020 | Details |
| A07930 | 32306652 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases]. | 2020 | Details |
| A07934 | 32306299 | Obes Surg | The Impact of Bariatric Surgery on Hepatic Function and Predictors of Liver Steatosis and Fibrosis. | 2020 | Details |
| A07940 | 32304142 | FASEB J | Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model. | 2020 | Details |
| A07942 | 32303415 | Eur J Surg Oncol | Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare? | 2020 | Details |
| A07943 | 32303170 | Curr Pharm Des | Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease. | 2021 | Details |
| A07947 | 32302728 | J Hepatol | Exercise retards hepatocarcinogenesis in obese mice independently of weight control. | 2020 | Details |
| A07955 | 32300166 | Sci Rep | Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity. | 2020 | Details |
| A07957 | 32299490 | BMC Res Notes | The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. | 2020 | Details |
| A07961 | 32298755 | Mol Cell Endocrinol | The offspring from rats fed a fatty diet display impairments in the activation of liver peroxisome proliferator activated receptor alpha and features of fatty liver disease. | 2020 | Details |
| A07966 | 32296880 | J Mol Med (Berl) | HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. | 2020 | Details |
| A07971 | 32293289 | BMC Gastroenterol | The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease. | 2020 | Details |
| A07972 | 32293287 | BMC Gastroenterol | Combined effects of lifestyle risk factors on fatty liver index. | 2020 | Details |
| A07978 | 32291578 | Indian J Gastroenterol | Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. | 2020 | Details |
| A07982 | 32290656 | J Agric Food Chem | Zinc Supplementation Alleviates Lipid and Glucose Metabolic Disorders Induced by a High-Fat Diet. | 2020 | Details |
| A07983 | 32290535 | Nutrients | Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. | 2020 | Details |
| A07985 | 32289885 | Cell Biochem Funct | Retinoic acid induced 16 deficiency exacerbates high-fat diet-induced steatohepatitis in mice. | 2020 | Details |
| A07987 | 32289432 | Life Sci | High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling. | 2020 | Details |
| A07988 | 32289180 | Eur J Clin Invest | Prevalence and risk factors of fatty liver in Portuguese adults. | 2020 | Details |
| A07993 | 32285676 | J Med Chem | Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08006 | 32281563 | J Oleo Sci | Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats. | 2020 | Details |
| A08008 | 32281248 | Liver Int | Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. | 2020 | Details |
| A08009 | 32280969 | Clin Infect Dis | Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus. | 2020 | Details |
| A08020 | 32279410 | J Anim Physiol Anim Nutr (Berl) | Campomanesia sp. flour attenuates non-alcoholic fatty liver disease on rats fed with a hypercaloric diet. | 2020 | Details |
| A08021 | 32279091 | Mamm Genome | Epigenetic contribution to obesity. | 2020 | Details |
| A08025 | 32278004 | J Hepatol | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. | 2020 | Details |
| A08033 | 32274915 | Minerva Pediatr | Metabolic syndrome in children. | 2020 | Details |
| A08034 | 32274348 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. | 2019 | Details |
| A08038 | 32272865 | Adipocyte | MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. | 2020 | Details |
| A08043 | 32271954 | Acta Paediatr | Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals. | 2020 | Details |
| A08044 | 32271385 | J Clin Endocrinol Metab | Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent. | 2020 | Details |
| A08046 | 32270583 | J Diabetes Investig | Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population. | 2020 | Details |
| A08048 | 32268517 | J Clin Med | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. | 2020 | Details |
| A08051 | 32268108 | Cell Metab | On the Front Line: Obesity and NAFLD. | 2020 | Details |
| A08055 | 32267269 | Food Funct | A lupine (Lupinus angustifolious L.) peptide prevents non-alcoholic fatty liver disease in high-fat-diet-induced obese mice. | 2020 | Details |
| A08056 | 32267017 | J Clin Lab Anal | Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease. | 2020 | Details |
| A08057 | 32266697 | Obes Surg | Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model. | 2020 | Details |
| A08061 | 32264657 | Korean J Intern Med | Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean. | 2020 | Details |
| A08062 | 32259637 | Mol Cell Endocrinol | Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice. | 2020 | Details |
| A08070 | 32258522 | Transl Gastroenterol Hepatol | Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. | 2020 | Details |
| A08071 | 32258520 | Transl Gastroenterol Hepatol | Epidemiology of non-alcoholic and alcoholic fatty liver diseases. | 2020 | Details |
| A08083 | 32253813 | J Cell Mol Med | Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition. | 2020 | Details |
| A08087 | 32252638 | BMC Gastroenterol | Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. | 2020 | Details |
| A08088 | 32252024 | J Endocrinol | miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway. | 2020 | Details |
| A08094 | 32249131 | Semergen | [Descriptive study of hepatic steatosis and associated morbidity in Primary Care. (ESTEATOAP Study)]. | 2020 | Details |
| A08098 | 32245940 | Med Sci Monit | Ganoderma Lucidum Polysaccharides Ameliorates Hepatic Steatosis and Oxidative Stress in db/db Mice via Targeting Nuclear Factor E2 (Erythroid-Derived 2)-Related Factor-2/Heme Oxygenase-1 (HO-1) Pathway. | 2020 | Details |
| A08103 | 32245414 | BMC Gastroenterol | Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. | 2020 | Details |
| A08105 | 32245128 | Nutrients | Increase of Akkermansia muciniphila by a Diet Containing Japanese Traditional Medicine Bofutsushosan in a Mouse Model of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08110 | 32243868 | Metabolism | Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model. | 2020 | Details |
| A08126 | 32238704 | Biol Pharm Bull | Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2020 | Details |
| A08129 | 32237015 | Pediatr Diabetes | Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity. | 2020 | Details |
| A08139 | 32231442 | Clin Med Insights Endocrinol Diabetes | Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism. | 2020 | Details |
| A08144 | 32230953 | Nutrients | Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. | 2020 | Details |
| A08145 | 32229588 | J Lipid Res | The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice. | 2020 | Details |
| A08148 | 32228845 | Med Sci (Paris) | [Emergence of 3D human fatty liver models engineered in the laboratory]. | 2020 | Details |
| A08152 | 32226553 | Theranostics | Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A08153 | 32226411 | Front Endocrinol (Lausanne) | Women Are at a Higher Risk of Chronic Metabolic Diseases Compared to Men With Increasing Body Mass Index in China. | 2020 | Details |
| A08155 | 32225108 | Int J Mol Sci | Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH). | 2020 | Details |
| A08156 | 32224733 | Ann Surg | Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis. | 2020 | Details |
| A08159 | 32223545 | Paediatr Int Child Health | The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017. | 2020 | Details |
| A08160 | 34908794 | Ayu | Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial. | 2021 | Details |
| A08162 | 32222944 | Indian J Gastroenterol | Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity. | 2020 | Details |
| A08174 | 32218179 | Biomolecules | A Sweet Connection? Fructose's Role in Hepatocellular Carcinoma. | 2020 | Details |
| A08175 | 32218121 | Nutrients | Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. | 2020 | Details |
| A08176 | 32217808 | J Endocrinol | Hepatic inflammation precedes steatosis and is mediated by visceral fat accumulation. | 2020 | Details |
| A08179 | 32217148 | Pharmacol Res | Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes. | 2020 | Details |
| A08183 | 32216545 | Tissue Eng Part B Rev | Fat-On-A-Chip Models for Research and Discovery in Obesity and Its Metabolic Comorbidities. | 2020 | Details |
| A08184 | 32216182 | Rev Med Suisse | [New trends in non-alcoholic fatty liver diseases (NAFLD)]. | 2020 | Details |
| A08186 | 32214246 | Nature | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. | 2020 | Details |
| A08187 | 32213734 | Endocr J | The risk factors for hepatic steatosis in patients with primary aldosteronism. | 2020 | Details |
| A08191 | 32212870 | Expert Rev Endocrinol Metab | Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: a literature review. | 2020 | Details |
| A08194 | 32211252 | Cureus | Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08195 | 32210914 | Front Endocrinol (Lausanne) | The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08200 | 32207804 | JAMA | Nonalcoholic Steatohepatitis: A Review. | 2020 | Details |
| A08201 | 32207583 | Adv Clin Exp Med | Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. | 2020 | Details |
| A08204 | 32207237 | Obes Rev | Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature. | 2020 | Details |
| A08206 | 32205419 | Gut | Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. | 2020 | Details |
| A08208 | 32205038 | Hepatobiliary Pancreat Dis Int | Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese. | 2020 | Details |
| A08211 | 32202947 | Arch Physiol Biochem | All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosis. | 2020 | Details |
| A08213 | 32201176 | Gastroenterology | Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. | 2020 | Details |
| A08214 | 32200381 | Obes Facts | The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. | 2020 | Details |
| A08218 | 32198617 | Obes Surg | Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery. | 2020 | Details |
| A08227 | 32192511 | J Transl Med | Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study. | 2020 | Details |
| A08233 | 32191646 | J Clin Invest | Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. | 2020 | Details |
| A08234 | 32191577 | J Med Food | Eriocitrin Improves Adiposity and Related Metabolic Disorders in High-Fat Diet-Induced Obese Mice. | 2020 | Details |
| A08235 | 32191400 | Clin Pharmacol Drug Dev | Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. | 2020 | Details |
| A08240 | 32190778 | Transl Gastroenterol Hepatol | Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . | 2020 | Details |
| A08245 | 32189926 | J Clin Exp Hepatol | Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment. | 2019 | Details |
| A08251 | 32188385 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease and Vascular Disease. | 2021 | Details |
| A08254 | 32187014 | J Pediatr Endocrinol Metab | Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review. | 2020 | Details |
| A08255 | 32185692 | Indian J Gastroenterol | Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A08260 | 32184638 | Diabetes Metab Syndr Obes | Lower Levels of Circulating Adiponectin in Elderly Patients with Metabolic Inflammatory Syndrome: A Cross-Sectional Study. | 2020 | Details |
| A08265 | 32181573 | Liver Int | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. | 2020 | Details |
| A08268 | 32179679 | Proc Natl Acad Sci U S A | Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. | 2020 | Details |